MBP
Click for more information
3.23% 3.0¢ metabolic pharmaceuticals limited

volume building for mbp, page-16

  1. jevalent
    5,260 Posts.
    lightbulb Created with Sketch. 242
    clock Created with Sketch.
    14/06/07
    03:05
    Post #: 2535384
    ...looks like this would be one of your competitors.

    Not really. It looks to me like this product is a treatment for nociceptive pain, not neuropathic pain like ACV1.

    Two different indications, two different markets.
    MBP Price at posting: 0.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
ABY Adore Beauty buys up wellness brand iKOU for $25M cash
right-arrow Created with Sketch.
NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.